1. Robert G,Roeder 美国 Rockefeller University 1988美国科学院院士;2003拉斯克奖 Germline Lysine-Specific Demethylase 1 (LSD1/KDM1A) Mutations Confer Susceptibility to Multiple Myel..
2. 詹启敏 中国 北京大学 中国工程院院士 miR-192-5p Silencing by Genetic Aberrations Is a Key Event in Hepatocellular Carcinomas with Cancer ..
3. 汤钊猷 中国 复旦大学上海医学院 中国工程院院士 miR-192-5p Silencing by Genetic Aberrations Is a Key Event in Hepatocellular Carcinomas with Cancer ..
4. Garber, Judy E. 美国 Harvard Medical School 2013美国医学院院士 Germline Lysine-Specific Demethylase 1 (LSD1/KDM1A) Mutations Confer Susceptibility to Multiple Myel..
5. Anderson, Kenneth C. 美国 Harvard Medical School 2010美国医学院院士 Germline Lysine-Specific Demethylase 1 (LSD1/KDM1A) Mutations Confer Susceptibility to Multiple Myel..
6. Daly, Mark J. 美国 Massachusetts General Hospital 2017美国医学院院士 Germline Lysine-Specific Demethylase 1 (LSD1/KDM1A) Mutations Confer Susceptibility to Multiple Myel..
7. Offit, Kenneth 美国 Memorial Sloan Kettering Cancer Center 2016美国医学院院士 Germline Lysine-Specific Demethylase 1 (LSD1/KDM1A) Mutations Confer Susceptibility to Multiple Myel..
8. Galle, Peter 德国 Universitätsmedizin Mainz Impact of body mass index in patients receiving atezolizumab plus bevacizumab for hepatocellular car..
9. Arndt,Vogel 德国 Hannover Medical School Impact of body mass index in patients receiving atezolizumab plus bevacizumab for hepatocellular car..
10. Masatoshi,Kudo 日本 Kinki University Impact of body mass index in patients receiving atezolizumab plus bevacizumab for hepatocellular car..
11. David J,Pinato 英国 Imperial College London Impact of body mass index in patients receiving atezolizumab plus bevacizumab for hepatocellular car..
12. Alejandro,Sosnik 以色列 Technion-Israel Institute of Technology Dermatan Sulfate/Chitosan Nanoparticles Loaded with an Anti-Inflammatory Peptide Increase the Respon..
13. Skolnick, Jeffrey 美国 School of Biological Sciences PHEVIR: an artificial intelligence algorithm that predicts the molecular role of pathogens in comple..
14. Srinivasan,Dasarathy 美国 Cleveland Clinic Hepatocellular Carcinoma in Patients Without Cirrhosis: The Fibrosis Stage Distribution, Characteris..
15. Arthur J,McCullough 美国 Cleveland Clinic Hepatocellular Carcinoma in Patients Without Cirrhosis: The Fibrosis Stage Distribution, Characteris..
16. 赖志政 中国 台湾奇美医院 Correlation of Body Mass Index with Oncologic Outcomes in Colorectal Cancer Patients: A Large Popula..
17. Lee, Po-Huang 中国 台湾义守大学 Correlation of Body Mass Index with Oncologic Outcomes in Colorectal Cancer Patients: A Large Popula..
18. Seyed Jalal,Hosseinimehr 伊朗 Mazandaran University Medicine Science Data on the in vitro and in vivo anti-tumor effects of itraconazole, paclitaxel, and the two in comb..
19. Piero,Portincasa 意大利 University of Bari Helicobacter pylori Virulence Factors-Mechanisms of Bacterial Pathogenicity in the Gastric Microenvi..
20. Mohammed,Eslam 澳大利亚 University of Sydney The Asian Pacific Association for the Study of the Liver clinical practice guidelines for the diagno..